Post - PharmD  training

PGY-1  resident

I completed a PGY-1 pharmacy residency at the Womack Army Medical Center (Ft. Bragg) in 2015. Here I trained to be a clinical pharmacist, patient advocate, and researcher under the guidance of truly amazing preceptors. Through their mentorship, I learned to care for, teach, assess, and treat patients with strokes, diabetes, hypertension, infections, atrial fibrillation, and a host of other health disorders. 

My capstone research as principal investigator, entitled "Factors Affecting Bleeds When Undergoing Dabigatran Therapy at a Military Treatment Facility", was presented in Athens (GA) at the Southeastern Residency Conference.

PGY-2/3  fellow

From 2018-2020, I trained as a clinical pharmacologist & research fellow at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. It was here where I learned to design clinical trials, analyze patient data, incorporate pharmacogenomics and biostatistics into research, create trial simulations and PK-PD/PBPK models with software (R, Berkeley Madonna, WinNonlin), and progress study drugs through Phase I-III trials.

I worked alongside dedicated professionals at the NIH, Walter Reed Army Medical Center, FDA, Fort Detrick, and Uniformed Services University of Health Sciences (USUHS), within the infectious diseases therapeutic area, with special emphasis on malaria and HIV. 

I had the privilege to be one of the CMC reviewers on the NDA packet of the drug "artesunate" for the FDA which was later granted approval for the treatment of severe malaria. The link below provides a description of the drug.

 

 

                Army                                   Officer

           Clinical      
     Pharmacologist             & Pharmacist

      FDA approved: 
       IV artesunate 

             When we share our       
       knowledge, we all prosper

* Indicates required fields
Thank you! We will get back to you as soon as possible.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.